Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 4
2005 2
2006 1
2007 4
2008 3
2009 3
2010 2
2011 3
2012 6
2013 2
2014 4
2016 6
2017 7
2018 3
2019 6
2020 9
2021 14
2022 7
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Real-World Evidence - What Is It and What Can It Tell Us?
Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, Shuren J, Temple R, Woodcock J, Yue LQ, Califf RM. Sherman RE, et al. Among authors: marks pw. N Engl J Med. 2016 Dec 8;375(23):2293-2297. doi: 10.1056/NEJMsb1609216. N Engl J Med. 2016. PMID: 27959688 No abstract available.
Scalable Manufacturing of CAR T cells for Cancer Immunotherapy.
Abou-El-Enein M, Elsallab M, Feldman SA, Fesnak AD, Heslop HE, Marks P, Till BG, Bauer G, Savoldo B. Abou-El-Enein M, et al. Among authors: marks p. Blood Cancer Discov. 2021 Sep;2(5):408-422. doi: 10.1158/2643-3230.BCD-21-0084. Epub 2021 Aug 3. Blood Cancer Discov. 2021. PMID: 34568831 Free PMC article. Review.
Enhancing gene therapy regulatory interactions.
Marks P. Marks P. Expert Opin Biol Ther. 2022 Sep;22(9):1073-1074. doi: 10.1080/14712598.2022.2060736. Epub 2022 Apr 3. Expert Opin Biol Ther. 2022. PMID: 35354351 No abstract available.
Audio Interview: The FDA and Covid-19 Vaccines.
Rubin EJ, Baden LR, Marks P, Morrissey S. Rubin EJ, et al. Among authors: marks p. N Engl J Med. 2022 Nov 17;387(20):e60. doi: 10.1056/NEJMe2214911. N Engl J Med. 2022. PMID: 36383718 No abstract available.
Audio Interview: Covid-19 Vaccines and the FDA.
Rubin EJ, Baden LR, Marks P, Morrissey S. Rubin EJ, et al. Among authors: marks p. N Engl J Med. 2022 Jul 14;387(2):e10. doi: 10.1056/NEJMe2209406. N Engl J Med. 2022. PMID: 35830648 No abstract available.
Scientific considerations for global drug development.
Wilson JL, Cheung KWK, Lin L, Green EAE, Porrás AI, Zou L, Mukanga D, Akpa PA, Darko DM, Yuan R, Ding S, Johnson WCN, Lee HA, Cooke E, Peck CC, Kern SE, Hartman D, Hayashi Y, Marks PW, Altman RB, Lumpkin MM, Giacomini KM, Blaschke TF. Wilson JL, et al. Among authors: marks pw. Sci Transl Med. 2020 Jul 29;12(554):eaax2550. doi: 10.1126/scitranslmed.aax2550. Sci Transl Med. 2020. PMID: 32727913 Free PMC article. Review.
What regulators must learn from COVID-19.
Marks P. Marks P. Nat Med. 2021 Nov;27(11):1858. doi: 10.1038/s41591-021-01559-4. Nat Med. 2021. PMID: 34711974 No abstract available.
Clarifying US regulations on xenotransplantation.
Marks P, Solomon S. Marks P, et al. Nat Biotechnol. 2021 Dec;39(12):1500-1501. doi: 10.1038/s41587-021-01144-7. Nat Biotechnol. 2021. PMID: 34857928 No abstract available.
Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
Young BC, Eyre DW, Kendrick S, White C, Smith S, Beveridge G, Nonnenmacher T, Ichofu F, Hillier J, Oakley S, Diamond I, Rourke E, Dawe F, Day I, Davies L, Staite P, Lacey A, McCrae J, Jones F, Kelly J, Bankiewicz U, Tunkel S, Ovens R, Chapman D, Bhalla V, Marks P, Hicks N, Fowler T, Hopkins S, Yardley L, Peto TEA. Young BC, et al. Among authors: marks p. Lancet. 2021 Oct 2;398(10307):1217-1229. doi: 10.1016/S0140-6736(21)01908-5. Epub 2021 Sep 14. Lancet. 2021. PMID: 34534517 Free PMC article. Clinical Trial.
Methodological Choices in Peer Nomination Research.
Cillessen AHN, Marks PEL. Cillessen AHN, et al. Among authors: marks pel. New Dir Child Adolesc Dev. 2017 Sep;2017(157):21-44. doi: 10.1002/cad.20206. New Dir Child Adolesc Dev. 2017. PMID: 28892286 Review.
90 results